Skip to main content
Equibles

STATE STREET CORP

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 93751 BOSTON, MA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$66,805,697
+$30,653,823 QoQ
Shares Held
3,668,627
+44.2% QoQ
Ownership
5.70%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 8% Shared 0% None 92%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. CGEM ranks #101 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in CGEM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $66,805,697 3,668,627
2026-03-31 $36,151,874 2,544,115
2025-12-31 $22,742,448 2,197,338
2025-09-30 $9,946,472 1,677,314
2025-06-30 $12,105,167 1,607,592
2025-03-31 $13,267,780 1,752,679
2024-12-31 $25,876,215 2,124,484
2024-09-30 $39,125,096 2,337,222
2024-06-30 $33,854,318 1,941,188
2024-03-31 $24,289,821 1,425,459
2023-12-31 $5,761,466 565,404
2023-09-30 $4,723,158 521,896
2023-06-30 $5,619,097 522,221
2023-03-31 $5,751,449 562,214
2022-12-31 $5,848,403 554,351
2022-09-30 $6,429,435 501,516
2022-06-30 $6,082,166 474,428
2022-03-31 $11,323,692 1,081,537
2021-12-31 $18,135,851 1,175,363
2021-09-30 $8,191,984 362,959
2021-06-30 $5,866,957 227,843
2021-03-31 $8,117,941 194,815